Evidence map›Paper›PMID 34605954›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2022

Optical coherence tomography predictors of progression of non-exudative age-related macular degeneration to advanced atrophic and exudative disease.

Sohani Amarasekera, Anindya Samanta, Mahima Jhingan, Supriya Arora, Sumit Singh, Davide Tucci, Marco Lupidi, Jay Chhablani, Age Related Macular Degeneration study group

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. RPE Curvature Can Screen for Early and Intermediate AMD.Investigative ophthalmology & visual science · 2024
    Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Sohani AmarasekeraUniversity of Pittsburgh Medical Center, 203 Lothrop Street, Pittsburgh, PA, 15213, USA.
Anindya SamantaTexas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.
Mahima JhinganJoan and Irwin Jacobs Retina Center, La Jolla, CA, USA.
Supriya AroraPrincess Margaret Hospital, Nassau, Bahamas.
Sumit SinghJoan and Irwin Jacobs Retina Center, La Jolla, CA, USA.
Davide TucciUniversita Degli Studi Di Perugia Facolta Di Medicina E Chirurgia, Perugia, Umbria, Italy.
Marco LupidiUniversita Degli Studi Di Perugia Facolta Di Medicina E Chirurgia, Perugia, Umbria, Italy.
Jay ChhablaniUniversity of Pittsburgh Medical Center, 203 Lothrop Street, Pittsburgh, PA, 15213, USA. jay.chhablani@gmail.com.ORCID http://orcid.org/0000-0003-1772-3558
Age Related Macular Degeneration study group
The Retina Center · USUniversity of Perugia · ITUniversity of Pittsburgh Medical Center · USTexas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo study the natural history of optical coherence tomography (OCT) imaging-based findings seen in non-exudative age-related macular degeneration (neAMD) and model their relative likelihood in predicting development of incomplete retinal pigment epithelium and outer retinal atrophy (iRORA), complete retinal pigment epithelium and outer retinal atrophy (cRORA), and neovascular AMD (nAMD).

methodsRetrospective chart review was performed at two academic practices. Patients diagnosed with neAMD for whom yearly OCT scans were obtained for at least 4 consecutive years were included. Baseline demographic, visual acuity, AREDS staging, and OCT data were collected. OCTs were assessed for the presence or absence of eleven features previously individually associated with progression of neAMD, both at baseline, and on all subsequent follow-up scans. Likewise, charts were reviewed to assess visual acuity and staging of NEAMD at all follow-up visits. A multivariate regression analysis was constructed to determine predictors of iRORA, cRORA, and nAMD.

resultsA total of 107 eyes of 88 patients were evaluated. Follow-up included yearly OCTs obtained over at least 4 consecutive years follow-up (range: 50-94 months). During the follow-up period, 17 eyes progressed to iRORA while 25 progressed to cRORA and 16 underwent conversion to nAMD. Predictors of conversion to iRORA and cRORA included integrity of the external limiting membrane (p = 0.02), the ellipsoid zone (p = 0.01), and the cone outer segment line (p = 0.003) and the presence of intraretinal hyporeflective spaces (p = 0.009), drusen ooze (p = 0.05), and drusen collapse (p = 0.001). OCT features predictive of conversion to nAMD included outer nuclear layer (ONL) loss (p = 0.01), presence of intraretinal (p = 0.001) and subretinal (p = 0.005) hyporeflective spaces, and drusen collapse (p = 0.003).

conclusionOf these multiple factors predictive of progression of neAMD, the OCT feature most strongly correlated to progression to iRORA/cRORA was drusen collapse, and the feature most predictive of conversion to nAMD was the presence of intraretinal hyporeflective spaces.

Indexed as

Tomography, Optical CoherenceWet Macular DegenerationAngiogenesis InhibitorsAtrophyDisease ProgressionFluorescein AngiographyHumansRetinal Pigment EpitheliumRetrospective StudiesVisual AcuityAngiogenesis InhibitorsAge-related macular degenerationComplete retinal pigment epithelium and outer retinal atrophyIncomplete retinal pigment epithelium and outer retinal atrophyOptical coherence tomography

Identifiers

PMID34605954
OpenAlexW3201791915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.